Attach a copy of patient's ID (.jpg, .pdf, .doc, .docx – less than 10 MB in size):
CONFERENCE ATTENDANCE FORM
Fifth Annual Cancer Care Forum at Clemenceau Medical Center
Friday-Saturday October 20-21, 2017 from 9:00am-6:00pm at the Conference Center B1
The aim of the forum is to provide an opportunity for multi-disciplinary healthcare providers to address different topics related to the care of cancer patients.
The forum is open for different disciplines including: physicians, laboratory pharmacists, pathologists, nurses, medical records personnel, medical directors, and hospital and health managers.
The participants are expected to:
1.Value the role of leadership in Cancer Care
2.Highlight the importance of research in Cancer
3.Update on Gastrointestinal Cancers
4.Integrate novel Radiotherapy procedures in the multimodality management of Cancer
5.Discuss recent indications of Immunotherapy
6.Identify the role of Cancer genetics
7.Recognize the impact of primary care physicians in the care of Cancer patients
8.Reinforce the role of multidisciplinary approach of Cancer care
9.Review recent regulatory approved new drugs in hemotologic malignancies
10.Review recent regulatory approved new drugs in solid tumors
Speakers from Johns Hopkins Medicine:
Dr. Daniel A. Laheru-Co-Director, Skip Viragh Center for Pancreas Cancer, Johns Hopkins Hospital & Professor of Oncology, Johns Hopkins University
Dr. Laheru currently serves as an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Laheru specializes in gastrointestinal oncology with a specific focus in pancreatic cancer. His clinical research interests are in developing and testing new therapies for the treatment of pancreatic cancer. He has developed a clinical trial program to optimize a vaccine approach using GM-CSF transfected pancreatic cell lines as a vaccine in two distinct patient populations.
Dr. Laheru has also incorporated correlative studies that should provide important information to better understand optimal vaccine boosting schedules as well as to identify antigens that can be predictive in-vitro markers for anti-tumor immune responses. He is investigating mechanisms of chemotherapy resistance in pancreatic cancer and will be developing and testing new targets for therapy in patients with metastatic pancreas cancer.
Katrina Alino Purtell, RN, MSN-Research Nurse Manager, Johns Hopkins University School of Medicine, Bloomberg~Kimmel Institute for Cancer Immunotherapy; Gastrointestinal, Cancer Immunotherapy and Melanoma Programs, The Sidney Kimmel Comprehensive Cancer Center
Katrina is a research nurse manager at the Johns Hopkins University School of Medicine. She received her bachelor of science in nursing degree in 2001 from University of Virginia School of Nursing. She received her master of science in nursing degree specializing in Health Systems Management from Johns Hopkins University School of Nursing in 2012.
Katrina started her oncology nursing career in 2001, at Virginia Hospital Center in Arlington, Virginia. She worked as a staff nurse on the leukemia and bone marrow transplant units at Johns Hopkins Hospital. She started her research nursing career at Johns Hopkins University in 2007 in the Hematologic Malignancies Program focusing on acute leukemia research. She has been with the Gastrointestinal, Cancer Immunotherapy & Melanoma Program since 2009. She orients and mentors research nurses. She is involved in research billing compliance, workload allocation and research operations at the Sidney Kimmel Comprehensive Cancer Center. In addition to her administrative duties, she is an active research nurse at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Fields marked with * are required